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Figure 1. Perlecan Expression as a Function of Bovine Donor Age
Figure 2. Perlecan Expression as a Function of Bovine Donor Age in 2 Year
Age Groups
Figure 3. Perlecan Expression inDynamically Loaded Juvenile Bovine CTAsĂ
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S60the complex spatial variation in association with predictor variables, as
defect trait combinations were shown to be signiﬁcantly related to age,
sex, and age x sex. In ongoing work, we are investigating the spatial
variation of cartilage thickness and subchondral bone composition and
we expect that incorporation of a comprehensive description of the
cartilage-subchondral bone region, in addition to animal characteristics,
such as age and sex, will further explain the causes of the onset and
development of osteoarthritis.
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Purpose: Perlecan is a large heparan sulfate proteoglycan (HSPG) that is
widely distributed throughout the body, involved in the development of
the musculoskeletal system and found in articular cartilage. Perlecan
can exert a number of functions, including cell adhesion, growth factor
delivery and sequestration, inﬂuencing the pericellular microenviron-
ment. HS bearing perlecan domain I binds several growth factors
important in cartilage growth, including BMP-2, serving as an effective
growth factor delivery system for chondrogenic cells. It is not known
what changes occur for perlecan expression in aging cartilage, and our
hypothesis is that if reduced, loss of perlecan would substantially
impact the biosynthetic activity of aging chondrocytes to maintain
proper cellular function. In this study we explored the changes of per-
lecan expression in a large number of bovine cartilages at various ages
and tested methods to increase perlecan expression via hydrostatic
loading, a component of the physiological loading environment.
Methods: For the study of perlecan expression as a function of donor
age, full thickness cartilage explants were harvested (<3 hours post
mortem) from bovine metacarpophalangeal joints. Macroscopically,
all animals were negative for any indications of osteoarthritis. mRNA
was isolated via the RNeasy mini kit, cDNA was prepared and gene
expression measured by SYBR-green qPCR using perlecan domain I
speciﬁc primers 5’-GTGACCCATGGGCTGAGGGCATA-3’ and
5’-GGGCACTGTGCCCAGGCGT-3’. Using the DCt method, the expres-
sion of perlecan was compared to the average of four housekeeping
genes; GAPDH, RPS14, RPL22 and Gusb. For loading studies, fresh
hyaline cartilage was harvested from the condyles and the trochlear
groove of juvenile bovine knees (3-6 months old). The cartilage was
digested overnight in DMEMwith collagenase type II. The suspension
was ﬁltered and chondrocytes were isolated by centrifugation and
aggregated in poly 2-hydroxyethyl methacrylate 96-well plates, cre-
ating cartilage tissue analogs (CTA) at 1 x 106 cells/CTA. CTAs for 1 and
2 loading sessions were matured 5.5 weeks and CTAs for 3 loading
sessions were matured 10 days prior to loading. A custom bioreactor
was utilized to apply dynamic loading (750 psi, 0.1 Hz, 3 hours) to the
CTAs. Loading was applied 1, 2 and 3 times a week for 1 week (n ¼ 3).
CTAs were harvested 72 hours after the ﬁnal loading session. mRNA
was isolated, cDNA synthesized with iScript and qPCR performed
using iTaq. Results were analyzed using the 2-DCt method for relative
gene expression to GAPDH.
Results: Perlecan expression in cartilage was determined in 41 bovine
donors from 0-12 years of age. An inverse correlation exists between
donor age and perlecan expression, as the amount of perlecan mRNA
decreaseswith donor age (Fig 1, 2). This ismore evidentwhen the donors
are grouped in 2 year age brackets (Fig 2). We see the most substantial
downregulation of perlecan after 2, 4 and 10 years (40.98%, 56.39% and
67.25%, respectively) when compared to the previous age group. By 10-
12 years of age, a drastic >90% downregulation of perlecan expression
was observed compared to the 0-2 year age group. Applying a physio-
logic, cyclic hydrostatic pressure load using a custom bioreactor, perle-
can expression was quantiﬁed under multiple dynamic loading
regimens using our CTAmodel. Perlecan expressionwas not altered by 1
loading session over 1 week (5.9%). However, speciﬁc loading regimens
of 2 and 3 loading cycles increased perlecan expression in CTA (198.8%
and 77.3%, respectively, Fig 3).While result values are consistent through
multiple experiments, they only approach statistical signiﬁcance.
Conclusions: In this study, we identiﬁed a signiﬁcant negative associ-
ation between age and perlecanmRNA expression via analysis of a large
cohort of fresh cartilage specimens. Given the increased predilection fordeveloping osteoarthritis with aging, this reduction in perlecan
expression suggests that perlecanmight play a role in protecting against
the degradation of cartilage and maintaining proper chondrocyte
function. Increased perlecan expressionwas observedwhen engineered
CTAs were exposed to physiologically relevant dynamic hydrostatic
loading. It is known that dynamic loading both improves cartilage
homeostasis and maintains the chondrogenic phenotype in cartilage.
Therefore, it can be suggested that perlecan expression in loaded CTAs is
a parallel to normal joint function and in vivo pressure. Our data sug-
gests that physiological loading might play a role in maintenance of
perlecan expression in adult cartilage and in this way contributes to
cartilage homeostasis.
